InVivo Therapeutics Receives Prestigious 2011 Apple Award for Top Publication in Breakthrough Spinal Cord Injury Research

InVivo Therapeutics Receives Prestigious 2011 Apple Award for Top Publication in Breakthrough Spinal Cord Injury Research
April 29, 2011
InVivo Therapeutics, a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that Chief Science Officer Dr. Christopher Pritchard, Ph.D., has been selected as the 2011 recipient of the American Spinal Injury Associations (ASIA) prestigious Apple Award. The award recognizes excellence in publishing in spinal cord injury research across the globe.
Read More